---
schema_version: "secwatch.filing_event.v1"
accession: "0001051514-23-000009"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2023-02-01T23:59:59+00:00"
generated_at: "2026-06-20T03:23:08.647216+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# STRATA reports record FY2022 revenue of $35-36M, up 17-19% YoY

## Summary
- Preliminary unaudited full-year 2022 revenue of $35-36M, vs $30M in 2021.
- Revenue at upper end of prior guidance of $33-35M.
- Growth driven by XTRAC usage, device redeployment, and international sales.
- Full audited results expected in March 2023.

## SEC filing metadata
- accession: 0001051514-23-000009
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2023-02-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000105151423000009/0001051514-23-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000105151423000009/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001051514-23-000009
- JSON: https://secwatch.observer/filing/0001051514-23-000009.json
- Plain text: https://secwatch.observer/filing/0001051514-23-000009.txt

## Key facts
- Earnings Releases
  STRATA Skin Sciences, Inc. reported the 2022 fiscal year results: revenue $35-$36 million. Guidance reaffirmed.
  - Period: the 2022 fiscal year
  - Revenue: $35-$36 million
  - Guidance: reaffirmed
  - Result: preliminary results
  source text: 2 ex_99-1.htm STRATA PRESS RELEASE DATED 2/1/2023 Exhibit 99.1 STRATA Skin Sciences Expects Record Full Year 2022 Revenue ● Unaudited, preliminary revenue within the range of $35-$36 million ● Record revenue represents approximately 17-19% growth over full year 2021 HORSHAM, Pa., February 1, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051514/000105151423000009/0001051514-23-000009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.